Co-stimulation Modulators -- a Novel Therapeutic Option for Rheumatoid Arthritis

ZHANG Zhuo-li,DONG Yi
DOI: https://doi.org/10.3321/j.issn:1003-3734.2006.11.003
2006-01-01
Abstract:The recently developed co-stimulatory modulator (Abatacept and LEA29Y) targets a-daptive immune system by modulating the co-stimulator of T cells. Clinical trials have provided preliminary evidence for efficacy of the drug in the treatment of rheumatoid arthritis. This review presents the potential of the co-stimulatory modulator in the viewpoints of basic immunology and outcomes of animal experiments and clinical trials, providing strategic thoughts for clinical use of the drug in China.
What problem does this paper attempt to address?